Go to main content

The new brand - AOP Health - emphasizes our patient-centric approach when developing integrated therapies for rare diseases and in critical care.

Dedicated to improving patients' lives

Our company has made a name for itself worldwide as the European pioneer in the field of rare diseases and in critical care. By founding OrphaCare in 2018 - now AOP Care - and taking over Amomed Pharma GmbH and SciPharm S.à.r.l. in 2020, we continued our systematic growth.

  • cardiology & pulmonology
  • critical care 
  • hemato-oncology
  • neurology & metabolic disorders

With one brand identity, we want to unite all areas of our group and put the focus on what is most important: Health

Needs. Science. Trust.

This claim underlines our dedication to developing integrated therapies in the field of rare diseases and in critical care, and making them available for patients worldwide. Improving their quality of life – whether it is rare diseases, critical care or 24/7 patient services – is and will remain our mission and motivation.

Mag. Andreas Steiner Group CEO AOP Health Group

„With our new brand name, we want to express our commitment to our patients, which has remained unchanged for a quarter century."

Focus on integrated solutions

Our ever-growing integrated network of medical solutions will benefit patients, patient organizations, physicians, scientists and all healthcare professionals, who find a trusted and committed long-term partner in AOP Health.